Latest filing published 08 Jun 2009 for Interpace Biosciences, INC., €32k.
No signal scores available.
This profile gathers the share dealings of John M. Pietruski across 2 companies, led by Encysive Pharmaceuticals Inc and Interpace Biosciences, Inc. In total, 16 filings cover trades dated from 31 December 2005 to 4 June 2009.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 8 June 2009 with a share grant (€32k) in Interpace Biosciences, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
16 of 16 declarations